| Issue Date | Title | Author(s) |
| 2019-05 | Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional survey. | Matsuoka, H; Tagami, K; Ariyoshi, K; Oyamada, S; Kizawa, Y; Inoue, A; Koyama, A |
| 2024-07 | Curbing the major and growing threats from invasive alien species is urgent and achievable. | Roy, HE; Pauchard, A; Stoett, PJ; Renard Truong, T; Meyerson, LA; Bacher, S; Galil, BS; Hulme, PE; Ikeda, T; Kavileveettil, S; McGeoch, MA; Nuñez, MA; Ordonez, A; Rahlao, SJ; Schwindt, E; Seebens, H; Sheppard, AW; Vandvik, V; Aleksanyan, A; Ansong, M; August, T; Blanchard, R; Brugnoli, E; Bukombe, JK; Bwalya, B; Byun, C; Camacho-Cervantes, M; Cassey, P; Castillo, ML; Courchamp, F; Dehnen-Schmutz, K; Zenni, RD; Egawa, C; Essl, F; Fayvush, G; Fernandez, RD; Fernandez, M; Foxcroft, LC; Genovesi, P; Groom, QJ; González, AI; Helm, A; Herrera, I; Hiremath, AJ; Howard, PL; Hui, C; Ikegami, M; Keskin, E; Koyama, A; Ksenofontov, S; Lenzner, B; Lipinskaya, T; Lockwood, JL; Mangwa, DC; Martinou, AF; McDermott, SM; Morales, CL; Müllerová, J; Mungi, NA; Munishi, LK; Ojaveer, H; Pagad, SN; Pallewatta, NPKTS; Peacock, LR; Per, E; Pergl, J; Preda, C; Pyšek, P; Rai, RK; Ricciardi, A; Richardson, DM; Riley, S; Rono, BJ; Ryan-Colton, E; Saeedi, H; Shrestha, BB; Simberloff, D; Tawake, A; Tricarico, E; Vanderhoeven, S; Vicente, J; Vilà, M; Wanzala, W; Werenkraut, V; Weyl, OLF; Wilson, JRU; Xavier, RO; Ziller, SR |
| 2023-06-01 | Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain | Matsuoka, H; Clark, K; Fazekas, B; Oyamada, S; Brown, L; Ishiki, H; Matsuda, Y; Hasuo, H; Ariyoshi, K; Lee, J; Le, BH; Fujiwara, N; Miyaji, T; Agar, MR; Yamaguchi, T; Satomi, E; Iwase, S; Phillips, J; Koyama, A; Currow, DC |
| 2023-06-01 | Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain. | Matsuoka, H; Clark, K; Fazekas, B; Oyamada, S; Brown, L; Ishiki, H; Matsuda, Y; Hasuo, H; Ariyoshi, K; Lee, J; Le, BH; Fujiwara, N; Miyaji, T; Agar, MR; Yamaguchi, T; Satomi, E; Iwase, S; Phillips, J; Koyama, A; Currow, DC |
| 2022-02-07 | Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol. | Matsuoka, H; Clark, K; Fazekas, B; Oyamada, S; Brown, L; Ishiki, H; Matsuda, Y; Hasuo, H; Ariyoshi, K; Lee, J; Le, B; Allcroft, P; Kochovska, S; Fujiwara, N; Miyaji, T; Lovell, M; Agar, M; Yamaguchi, T; Satomi, E; Iwase, S; Phillips, J; Koyama, A; Currow, DC |
| 2020 | Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial—JORTC-PAL08 (DIRECT) study | Matsuoka, H; Iwase, S; Miyaji, T; Kawaguchi, T; Ariyoshi, K; Oyamada, S; Satomi, E; Ishiki, H; Hasuo, H; Sakuma, H; Tokoro, A; Matsuda, Y; Tahara, K; Otani, H; Ohtake, Y; Tsukuura, H; Matsumoto, Y; Hasegawa, Y; Kataoka, Y; Otsuka, M; Sakai, K; Nakura, M; Morita, T; Yamaguchi, T; Koyama, A |
